Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2014 · 10-Q
Revenue$109.48M$109.48M+7.3% vs Q1 2013 Net Income$4.75M$4.75M+8.8% vs Q1 2013 EPS Diluted$0.18$0.18+5.9% vs Q1 2013 Gross Profit$12,532,000−8.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$4,538,000−10.8% Free Cash Flowderived$193,000−93.7% Margins · derivedGross margin11.4%−2.0 pt vs Q1 2013
Operating margin1.8%−1.1 pt vs Q1 2013
Net margin4.3%+0.1 pt vs Q1 2013
ended Aug 25, 2013 · filed Sep 26, 2013 · 32 d after period end